Cenestin and adenocarcinoma pancreas Patient Reports February 11, 2012

Cenestin Side Effects Report #5402776-3
Cenestin side effect was reported by a Health Professional from JAPAN on July 19, 2007. Female patient, 50 years of age, was diagnosed with menopausal disorder and was treated with Cenestin. After drug was administered, patient experienced the following side effects: adenocarcinoma pancreas, condition aggravated, oestrogen receptor assay positive, pancreatic cyst, progesterone receptor assay positive. Cenestin dosage: 0.625 MG, QD; ORAL. Patient was hospitalized. Patient recovered.